Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.
Abstract
The fibroblast component of adipose tissue is the primary extraglandular site of aromatase P450 (P450arom) expression, which is responsible for the conversion of C19 steroids to estrogens. Previously, we have shown positive correlations between the level of P450arom transcripts and the ratio of fibroblasts to mature adipocytes in adipose tissue samples proximal to breast tumors. The present study was conducted to determine the distribution of P450arom messenger ribonucleic acid (RNA) levels and fibroblast to adipocyte ratios in disease-free breasts of premenopausal women. Adipose tissue samples were collected from 3 regions (outer, upper, and inner) of both breasts of 13 women undergoing reduction mammoplasty. The histological composition of adipose tissue (n = 12) was determined by morphometry using a computerized image analysis program. We used a competitive RT-PCR method employing rat P450arom complementary RNA as an internal standard to quantify adipose P450arom transcripts in tissue total RNA samples (n = 11). Overall, 67% of the highest fibroblast to adipocyte ratios and 64% of the highest P450arom transcript levels were detected in an outer breast region, whereas in only 1 patient were the highest values detected in an inner region. Parametric ANOVA showed significant differences between the fibroblast content of the regions [p(F) = 0.037]. This distribution pattern directly correlates with the most common or the least common sites of carcinoma in the breast, the outer and inner regions, respectively. Moreover, a direct relationship was demonstrated between adipose fibroblasts and P450arom transcripts within the breast, in that regions with the highest fibroblast to adipocyte ratios contained the highest P450arom transcript levels (by ANOVA of contrast variables, P = 0.0009). These results suggest that, similar to our previous findings in the breast bearing a tumor, adipose tissue aromatase expression in the disease-free breast is determined by the local ratio of fibroblasts to adipocytes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 7 | |
| 시술 | reduction mammoplasty
|
유방성형술 | dict | 1 | |
| 해부 | adipose fibroblasts
|
scispacy | 1 | ||
| 해부 | adipose tissue
|
scispacy | 1 | ||
| 해부 | fibroblasts
|
scispacy | 1 | ||
| 해부 | adipocytes
|
scispacy | 1 | ||
| 해부 | adipose tissue samples
|
scispacy | 1 | ||
| 해부 | fibroblast
|
scispacy | 1 | ||
| 해부 | adipocyte
|
scispacy | 1 | ||
| 해부 | breasts
|
scispacy | 1 | ||
| 해부 | adipose
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | inner
|
scispacy | 1 | ||
| 해부 | adipose tissue aromatase
|
scispacy | 1 | ||
| 합병증 | extraglandular
|
scispacy | 1 | ||
| 약물 | steroids
|
C0038317
Steroids
|
scispacy | 1 | |
| 약물 | estrogens
|
C0014939
estrogens
|
scispacy | 1 | |
| 약물 | ribonucleic acid
|
C0035668
RNA
|
scispacy | 1 | |
| 약물 | C19 steroids
|
scispacy | 1 | ||
| 질환 | breast tumors
|
C1458155
Mammary Neoplasms
|
scispacy | 1 | |
| 질환 | breasts of 13 women undergoing reduction
|
scispacy | 1 | ||
| 질환 | carcinoma
|
C0007097
Carcinoma
|
scispacy | 1 | |
| 질환 | tumor
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 기타 | aromatase P450
|
scispacy | 1 | ||
| 기타 | human breast
|
scispacy | 1 | ||
| 기타 | P450arom
|
scispacy | 1 | ||
| 기타 | upper
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | rat P450arom
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
MeSH Terms
Adipose Tissue; Aromatase; Breast; Female; Fibroblasts; Humans; Premenopause; RNA, Messenger; Tissue Distribution
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.